Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Clinical trial NCT02278185 · COMPLETED

Trial details

NCT number: NCT02278185
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer

Start date: 2015-11-11
Primary completion: 2019-04-10
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.